Posts Tagged ‘heart’

Also, what are some foods that will lower his blood pressure and sugar?

{answer}

fatnews.com Hi, this is Larry Hobbs @ FatNews.com. The diet drug Meridia (sibutramine) increases the risk of heart attack, stroke and cardiac arrest in older people with a history of heart disease or Type 2 diabetes according to information released from the US Food and Drug Administration on November 20th, 2009. Hi, this is Larry Hobbs @ FatNews.com. LarryHobbs@FatNews.com fatnews.com In a study of 10000 patients over the last 7 years (since 2002), more people given Meridia had a heart attack, stroke or cardiac arrest than those given a placebo. Cardiovascular events occurred in 11.4% of patients given Meridia versus 10% of those given a placebo. This difference is higher than expected, suggesting that sibutramine is associated with an increased cardiovascular risk in the study population. the FDA noted. Patients included in the study were 55 years of age or older, overweight or obese, and had a history of heart disease or type 2 diabetes plus one additional cardiovascular risk factor. The preliminary study findings highlight the importance of avoiding the use of sibutramine in patients with a history of coronary artery disease (heart disease), congestive heart failure (CHF), arrhythmias, or stroke…

Video interview with Amanda Fretts, MPH, from the Saturated Fat and Processed Meat Consumption and Incident Impaired Fasting Glucose and Type 2 Diabetes in American Indians: The Strong Heart Family Study. EPI/NPAM 2011 Scientific Sessions.

A new analysis of several previous studies confirms that taking rosiglitazone, more commonly known as Avandia, actually increases the chances of having a heart attack but not the risk of dying of a cardiovascular cause. The study is published online ahead of print in the Archives of Internal Medicine. Here is some information about rosiglitazone: • It is a drug used to treat type 2 diabetes, which works by helping to increase the body’s sensitivity to insulin • Insulin helps the cells of the body absorb sugar, so the increased sensitivity to insulin helps reduce the abnormally high blood sugar levels seen in type 2 diabetes • Controversy has surrounded the drug in the past few years because of early studies suggesting it might increase the risk of heart attack and perhaps death from cardiovascular causes Researchers from The Cleveland Clinic Foundation analyzed data taken from 56 studies looking at the effects of rosiglitazone on cardiovascular adverse events, such as heart attacks and strokes. More than 35000 patients were included in these studies. Taking rosiglitazone was associated with a 28% increased risk of having a heart attack. The risk of dying from a cardiovascular cause was not higher among those taking this drug, however. We spoke with Dr. Steve Nissen, one of the investigator’s of this study, who offered some further insight. Today’s research confirms earlier findings that the risks of taking rosiglitazone may well outweigh the benefits.

Almonds May Help Reduce Risk Of Type 2 Diabetes And Heart Disease
With nearly 16 million Americans living today with prediabetes, a condition that is the precursor to type 2 diabetes, and half of all Americans expected to have either prediabetes or type 2 diabetes by the year 2020, nutritional approaches to maintaining healthy blood sugar levels are essential.1,2 The findings of a scientific study examining the health promotion and disease prevention benefits …

Read more on Medical News Today

You Docs: See the Mediterranean diet as food fuel to fight heart disease
A Mediterranean diet defends you from memory loss, depression and joint pain, and it tastes darn good, too.

FDA panel sees greater heart risks with Avandia
WASHINGTON – Federal health experts said today that the much-debated diabetes pill Avandia increases the risk of heart attack compared to other diabetes drugs.

American Heart Association Comment: Advisory Committee Recommends that U.S. Food and Drug Administration Keep …
DALLAS, July 14 /PRNewswire-USNewswire/ — After two days of hearings, an advisory committee to the U.S. Food and Drug Administration (FDA) recommended that the FDA allow the type 2 diabetes drug rosiglitazone (brand name, Avandia), to stay on the market, but with most committee members suggesting that the label be revised to include increased warnings. Rosiglitazone is one in a class of drugs …

Avandia Heart Risks Buried by Drug Company: Report
Report shows diabetes drug maker knew 11 years ago that Avandia caused heart problems.

Avandia’s heart risks under review in U.S.
A U.S. review reinforces potential ties between the Type 2 diabetes pill Avandia and heart attack and death, opening the door for U.S. government action.